
Today’s trading in biotech and healthcare was rough, once again. However, we did get some long signals for a couple stocks, EVH and FCSC. The later was actually triggered late yesterday but was still active today. Overall, upside potential seems strongest for generic healthcare stocks, but biotech has begun to catch up. Here’s what happened.